Table 3.
Examples of marmoset use in pharmacodynamic studies.
| Field | Disease/model |
|---|---|
| Neuroscience | Multiple sclerosis |
| Parkinson’s | |
| Huntington’s | |
| Stroke | |
| Alzheimer’s | |
| Absence epilepsy | |
| Aging | |
| Spinal injury | |
| Immunology | Thymic epithelium |
| Interleukin 2 and 4 | |
| Amyloid A (AA) amyloidosis | |
| Induced thrombocytopenia purpurea | |
| Infectious disease | Hepatitis |
| Eastern equine encephalitis | |
| Severe acute respiratory syndrome | |
| Acute oncogenesis | |
| Viral persistence | |
| HIV | |
| Measles pathogenesis | |
| Anthrax | |
| Smallpox virus infection | |
| Viral hemorrhagic fevers | |
| Other | Reproductive biology and immuno-contraception |
| Bone disease | |
| Human physiology | |
| Behavioral | |